Holtan, Shernan G.
294  results:
Search for persons X
?
 
?
5

Phase II Study of Myeloablative 7-8/8-Matched Allotransplan..:

Jurdi, Najla El ; Hoover, Alex ; O'Leary, Daniel...
Transplantation and Cellular Therapy.  29 (2023)  9 - p. 576.e1-576.e5 , 2023
 
?
6

Phase II, Open-Label Clinical Trial of Urinary-Derived Huma..:

Holtan, Shernan G. ; Hoeschen, Andrea ; Cao, Qing...
Transplantation and Cellular Therapy.  29 (2023)  8 - p. 509.e1-509.e8 , 2023
 
?
7

The best GVHD prophylaxis: Or at least progress towards fin..:

Weisdorf, Daniel ; El Jurdi, Najla ; Holtan, Shernan G.
Best Practice & Research Clinical Haematology.  36 (2023)  4 - p. 101520 , 2023
 
?
 
?
 
?
14

Health-Related Quality of Life Outcomes in Older Hematopoie..:

Hong, Sanghee ; Zhao, Jing ; Wang, Shu...
Transplantation and Cellular Therapy.  29 (2023)  3 - p. 202.e1-202.e8 , 2023
 
?
15

Patient-Reported Outcomes in Long-Term Survivors of Autolog..:

Chakraborty, Rajshekhar ; Yi, Jean ; Rybicki, Lisa...
Transplantation and Cellular Therapy.  29 (2023)  6 - p. 388.e1-388.e6 , 2023
 
1-15